Bergenbio ASA (BGBIO)

Currency in NOK
1.15
-0.04(-3.37%)
Closed·
BGBIO Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Earnings results expected in 7 days
BGBIO is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.141.20
52 wk Range
1.0215.67
Key Statistics
Prev. Close
1.15
Open
1.2
Day's Range
1.14-1.2
52 wk Range
1.02-15.67
Volume
167.34K
Average Volume (3m)
332.36K
1-Year Change
-89.94%
Book Value / Share
3.14
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BGBIO Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock has taken a big hit over the last week

Bergenbio ASA News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Bergenbio ASA Company Profile

BerGenBio ASA, a clinical-stage biopharmaceutical company, engages in the development of medicines to treat drug resistant, metastatic cancers, and respiratory disease in Norway. It develops BGBIL025, a JAK2 inhibitor indicated, which is in Ph1b/2a for treatment of the bone marrow disorder myelofibrosis. The company was incorporated in 2007 and is based in Bergen, Norway.

Compare BGBIO to Peers and Sector

Metrics to compare
BGBIO
Peers
Sector
Relationship
P/E Ratio
−0.3x−3.3x−0.5x
PEG Ratio
0.00−0.050.00
Price/Book
0.4x2.1x2.6x
Price / LTM Sales
53.0x7.0x3.3x
Upside (Analyst Target)
65.2%37.4%41.6%
Fair Value Upside
Unlock13.1%5.9%Unlock

Earnings

Latest Release
May 21, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

BGBIO Income Statement

FAQ

What Stock Exchange Does Bergenbio Trade On?

Bergenbio is listed and trades on the Oslo Stock Exchange stock exchange.

What Is the Stock Symbol for Bergenbio?

The stock symbol for Bergenbio is "BGBIO."

What Is the Bergenbio Market Cap?

As of today, Bergenbio market cap is 44.79M.

What Is Bergenbio's Earnings Per Share (TTM)?

The Bergenbio EPS (TTM) is -3.95.

When Is the Next Bergenbio Earnings Date?

Bergenbio will release its next earnings report on 19 Aug 2025.

From a Technical Analysis Perspective, Is BGBIO a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Bergenbio Stock Split?

Bergenbio has split 4 times.

How Many Employees Does Bergenbio Have?

Bergenbio has 13 employees.

What is the current trading status of Bergenbio (BGBIO)?

As of 13 Aug 2025, Bergenbio (BGBIO) is trading at a price of 1.15, with a previous close of 1.15. The stock has fluctuated within a day range of 1.14 to 1.20, while its 52-week range spans from 1.02 to 15.67.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.